NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,066 | +0.9% | 89 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,981 | +306.7% | 89 | +270.8% | 0.00% | +200.0% |
| Q1 2023 | $2,208 | +1.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,177 | -99.9% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,824,000 | -10.1% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,029,000 | -9.8% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,250,000 | +7.2% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,099,000 | +6.9% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,963,000 | -4.3% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,052,000 | -9.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,266,000 | +8.6% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,087,000 | -0.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,096,000 | +104700.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |